H.R. 10150 · 119th Congress · Referred to the House Committee on Energy and Commerce.
To amend the Federal Food, Drug, and Cosmetic Act to provide a period of market exclusivity for botanical drugs, and for other purposes.
We have not deep-analyzed this bill yet.
Here is what Congress.gov shows.
Public record
Below is the official voting record from Congress.gov. It is not our analysis.
Source: Congress.gov
This bill has no recorded roll-call vote yet. A roll-call vote records how each member voted by name.
Help keep this free. Support this work.
to get an email when it changes. Part of email alerts, $5 a month.